Trials / Completed
CompletedNCT05755373
A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 602 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this survey is to collect information for scientific research and to better understand the role of systemic inflammation in identification, treatment and management of patients with ASCVD and CKD. This study is a cross-sectional design conducted among cardiologists in United Kingdom, Italy, Germany, Brazil, Saudi Arabia, Japan, Australia, China, India and France, treating ASCVD and CKD patients. Study participants will be recruited to complete an approximately 20-minute self-administered online survey. Recruitment will be conducted through email and phone. Data is collected though online data collection using a programmed survey.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | No treatment given |
Timeline
- Start date
- 2023-03-24
- Primary completion
- 2023-05-15
- Completion
- 2023-05-15
- First posted
- 2023-03-06
- Last updated
- 2023-06-09
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT05755373. Inclusion in this directory is not an endorsement.